Overview

A Study of Retatrutide (LY3437943) Once Weekly in Participants Who Have Obesity or Overweight and Osteoarthritis of the Knee

Status:
Recruiting
Trial end date:
2026-03-08
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and efficacy of retatrutide once-weekly in participants who have obesity or are overweight and have osteoarthritis (OA) of the knee. The study will lasts about 77 weeks.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company